 |
|
No link found between low androgen levels and low sexual function in women
July 06, 2005No single androgen (sex hormone) level was found to be predictive of low sexual function in women, according to a study in the July 6 issue of JAMA.
Sexual dysfunction, primarily low libido, is common among women, with prevalences of 8 percent to 50 percent, according to background information in the article. Although multiple psychosocial and health factors contribute to low sexual desire and arousal, it has been proposed that androgen levels are significant independent determinants of sexual behavior in women. It is widely believed that a low serum free testosterone level is the diagnostic marker for the cluster of symptoms described as characterizing "female androgen insufficiency" based on therapeutic trials, and expert opinion. However, evidence that a low serum testosterone level distinguishes women with low sexual function from others, is lacking.
Susan R. Davis, M.D., Ph.D., of Monash Medical School, Alfred Hospital, Victoria, Australia, and colleagues conducted a study to determine if low self-reported sexual function is associated with low serum androgen levels. The study included 1,423 women aged 18 to 75 years who were randomly recruited from April 2002 to August 2003. Women were excluded from the analysis if they were younger than 45 years and using oral contraception. Women were surveyed with the Profile of Female Sexual Function (PFSF) and serum levels of total and free testosterone, androstenedione (an androgenic steroid), and dehydroepiandrosterone sulfate (DHEAS, a natural steroid hormone) were measured.
The researchers write: "We found no evidence of associations between low scores for any of the sexual domains evaluated and low serum total and free testosterone levels. In contrast, we observed significant associations between low sexual desire, arousal, and responsiveness in younger women [aged 18 to 44 years] and low responsiveness in older women [aged 45 years or older] and low serum DHEAS level relative to age."
"In addition to demonstrating that the measurement of testosterone is not useful for the diagnosis of the proposed female androgen insufficiency syndrome, our findings also do not support a diagnostically useful role for the measurement of DHEAS. This is because despite the increased likelihood that women with low sexual function have a low DHEAS level, the majority of women with a low DHEAS level did not report low sexual function," the authors write.
"Our results are not in conflict with testosterone being used pharmacologically to treat [abnormally inactive] sexual desire disorder, nor do they provide support for efficacy of DHEA therapy. Rather, our data, taken together with what is already known about the intracrine [a type of hormone function] physiology, suggest that sex steroids influence female sexual function, but that there is no serum androgen level that defines female androgen insufficiency. The measurement of serum testosterone, free testosterone, or DHEAS in individuals presenting with low sexual function is not informative and levels of these hormones should not be used for the purpose of diagnosing androgen insufficiency in women," the researchers conclude.
JAMA and Archives Journals
The researchers write: "We found no evidence of associations between low scores for any of the sexual domains evaluated and low serum total and free testosterone levels. In contrast, we observed significant associations between low sexual desire, arousal, and responsiveness in younger women [aged 18 to 44 years] and low responsiveness in older women [aged 45 years or older] and low serum DHEAS level relative to age."
"In addition to demonstrating that the measurement of testosterone is not useful for the diagnosis of the proposed female androgen insufficiency syndrome, our findings also do not support a diagnostically useful role for the measurement of DHEAS. This is because despite the increased likelihood that women with low sexual function have a low DHEAS level, the majority of women with a low DHEAS level did not report low sexual function," the authors write.
"Our results are not in conflict with testosterone being used pharmacologically to treat [abnormally inactive] sexual desire disorder, nor do they provide support for efficacy of DHEA therapy. Rather, our data, taken together with what is already known about the intracrine [a type of hormone function] physiology, suggest that sex steroids influence female sexual function, but that there is no serum androgen level that defines female androgen insufficiency. The measurement of serum testosterone, free testosterone, or DHEAS in individuals presenting with low sexual function is not informative and levels of these hormones should not be used for the purpose of diagnosing androgen insufficiency in women," the researchers conclude.
JAMA and Archives Journals
Androgen Current Events and Androgen News RSSWhy the 'perfect' body isn't always perfect
Having an imperfect body may come with some substantial benefits for some women, according to a new article in the December issue of Current Anthropology.
Hormone therapy before radiation seed implants for prostate cancer
Men over 70 years of age with early-stage prostate cancer have 20 percent higher mortality if they are treated first with hormone therapy before being treated with radiation seed implants (brachytherapy), compared to men who are treated with brachytherapy alone.
Why a common treatment for prostate cancer ultimately fails
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences.
Inheritance of hormonal disorder marked by excessive insulin in daughters
Elevated levels of insulin could be an early sign that girls whose mothers suffer from polycystic ovary syndrome -- or PCOS -- may also be susceptible to the disease, according to gynecologists who have found evidence of insulin resistance in young children.
Prostate cancer patients undergoing hormone therapy may experience cognitive effects
A recent review of the literature has found that hormone deprivation therapy, a commonly used treatment for prostate cancer, may have subtle adverse effects on cognition in patients-- such as in the ability to recall and concentrate.
OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers.
How advanced prostate cancer becomes resistant to androgen-deprivation therapy
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy.
Estrogen Helps Drive Distinct, Aggressive Form of Prostate Cancer
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers.
Many men with low testosterone levels do not receive treatment
The majority of men with androgen deficiency may not be receiving treatment despite having sufficient access to care, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Study shows that prostate cancer increases the risk of bone fracture
As unlikely as it sounds, scientists at the Garvan Institute for Medical Research have shown that there is a link between prostate cancer and a higher risk of bone fracture.
More Androgen Current Events and Androgen News Articles
 | Androgens in Health and Disease (Contemporary Endocrinology) (Contemporary Endocrinology) Authoritative researchers and clinicians review our latest understanding of andrology in both basic science and clinical medicine. Topics range from explaining the biology of androgens-from several different perspectives-to illuminating their role in the development and modulation of physiologic systems. Authors demonstrate in a number of cases that testosterone can be a useful adjunct to the... |
 | Androgen Disorders in Women by Theresa Cheung Androgen disorders are perhaps the most common and overlooked of female hormonal problems. Women's health writer Theresa Cheung describes how the hormone imbalance affects women both physically and emotionally, explaining how these disorders can be treated by conventional and alternative means and noting ways to prevent the problem as... |
 | Androgen Excess Disorders in Women (Contemporary Endocrinology) This thoroughly revised and comprehensive edition of a highly praised classic, Androgen Excess Disorders in Women covers the growing importance of polycystic ovary syndrome (PCOS) as the most prevalent androgen excess disorder in women. This volume addresses the latest research findings on the etiology, pathophysiology, clinical manifestations, genetics, and consequences of androgen excess... |
 | Androgen Deficiency in The Adult Male: Causes, Diagnosis and Treatment by Malcolm Carruthers Just what is the andropause? Although acceptance of the andropause concept by the medical community is growing, it is still a hotly debated issue. But as a busy clinician you have patients to treat and you need information. So where can you find the information you need to understand, diagnose, and treat this condition? A comprehensive, detailed clinical resource, Androgen Deficiency in the Adult... |
 | Androgen Insensitivity Syndrome - A Bibliography and Dictionary for Physicians, Patients, and Genome Researchers by Philip M. Parker In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading." Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing.... |
 | Androgen Insensitivity Syndrome Medical Guide by Qontro Medical Guides The Androgen Insensitivity Syndrome Medical Guide is a publication which has been designed to better help readers understand Androgen Insensitivity Syndrome. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Androgen Insensitivity Syndrome. The Androgen Insensitivity Syndrome Medical Guide... |
| Androgen; Prevention.(prevention of androgen disorders): An article from: NWHRC Health Center - Androgen by Gale Reference Team This digital document is an article from NWHRC Health Center - Androgen, published by Thomson Gale on December 23, 2005. The length of the article is 731 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Androgen deficit linked to QT prolongation in men.(Urology): An article from: Internal Medicine News by Mitchel L. Zoler This digital document is an article from Internal Medicine News, published by International Medical News Group on November 15, 2004. The length of the article is 434 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... | |
 | Androgens and Androgen Receptor: Mechanisms, Functions, and Clinical Applications Androgen Receptors is the most comprehensive and up to date volume on the topic, including discussions of the basic mechanisms of androgen-androgen receptor actions, their roles in the androgen-related diseases, and their potential clinical applications. Key topics covered include: + The discovery and cloning of the androgen receptor; + Androgen receptor coregulators; +... |
| Androgen; Overview.: An article from: NWHRC Health Center - Androgen This digital document is an article from NWHRC Health Center - Androgen, published by National Women's Health Resource Center on March 16, 2005. The length of the article is 1213 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web... |
| © 2008 BrightSurf.com |